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Case presentation
A previously healthy 19-year old female presented to the 
gynaecological clinic with gradual abdominal distension 
for six months, associated with progressive abdominal 
discomfort. There was no history of  nausea, vomiting, 
weight loss, or anorexia. She reported no changes in bowel 
habits and denied genitourinary symptomatology. Menarche 
occurred at 14 years of  age, and her menstrual periods had 
always been regular. She denied recent sexual activity and 
was not currently taking oral contraceptives. The remainder 
of  the patient’s history, including a focused family history, 
was non-contributory.
Physical examination revealed the presence of  a somewhat 
firm, irregular, nontender, and mobile mass arising from 
the pelvis, corresponding in size to a pregnant uterus of  24 
weeks’ gestation.
Laboratory analysis showed a blood haemoglobin 
concentration of  12.6 g/dL. The remainder of  her laboratory 
results were within physiological parameters, and pregnancy 
was excluded.
Transabdominal ultrasonography revealed globular uterine 
enlargement and a hypoechoic mass measuring 18 cm × 14 
cm. The ovaries and adnexa were not visualized because they 
were obscured by the enlarged, bulky uterus. Neither ascites 
nor hydronephrosis was noted. The patient was counselled 
about the diagnosis of  uterine fibroid and underwent 
exploratory laparotomy after proper counselling and written 
informed consent.
Intraoperatively, the uterus was grossly enlarged by a large 
fibroid measuring 16 cm x 10 cm (Figure 1 and Figure 2). 
Both ovaries and fallopian tubes were normal. 
Figure 1: Intraoperative image of the exteriorized uterus, showing the 
large fundal leiomyoma
Figure 2: Excised leiomyoma after myomectomy
The uterus was elevated out of  the abdominal cavity and 
myomectomy of  the large tumour was achieved through a 
fundal incision. The excision site was closed with continuous 
catgut sutures, and the abdomen was closed in layers. Cut 
section of  the gross specimen revealed whitish nodules with 
a whorled appearance and fibroelastic consistency suggestive 
of  benign leiomyoma (Figure 3). The specimen was sent 
for formal histopathology. Results of  histopathological 
examination confirmed the diagnosis of  a benign fibroid of  
the uterus.
Figure 3: Sectional view of excised leiomyoma, showing the typical 
nodular, whorled appearance, and fibroelastic consistency
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The patient’s postoperative course was uneventful, and she 
was discharged on postoperative day seven. A six-month 
follow-up with repeat ultrasonography was arranged. 
Counselling regarding recurrence and future fertility 
was offered before discharge. Though our client was an 
adolescent and denied being sexually active, she was offered 
family planning counselling and advised not to conceive for 
at least one year to allow wound healing and full recovery.
Discussion
Uterine leiomyomas (also called fibroids) are benign growths 
that represent the most common neoplasms of  the uterus, 
affecting 20% to 30% of  women between the ages of  30 and 
50 years.1-4 Their occurrence in the adolescent population 
(under the age of  20 years) is infrequent and relatively few 
cases have been documented in the literature.5-12
The aetiology of  leiomyomas in adolescents and adults is 
generally unknown, but leiomyomas are known to grow in 
response to both oestrogen and progesterone stimulation, 
and their prevalence increases throughout the reproductive 
years and is markedly reduced after menopause.5-8 Higher 
concentrations of  oestrogen and progesterone receptors, 
as well as aromatase, have been observed in fibroids 
compared to normal myometrial tissue.13-15 Early menarche, 
exposure to exogenous oestrogen, obesity, and pregnancy 
usually influence fibroid growth.5-8 Pregnancy and obesity 
were excluded in our patient as well as any history of  
administration of  hormonal agents. Our patient admitted to 
being a regular consumer of  red meat and broiler chickens. 
Some experts have linked the consumption of  red meat and 
broiler chickens (possible sources of  exogenous steroids) 
with the growth of  fibroids in younger women, but there is 
a lack of  published evidence to support this hypothesis.
A genetic component of  the pathogenesis of  uterine fibroids 
has also been suggested.16,17 High-frequency mutations 
involving chromosomes 6, 7, 12, and 14 have been reported 
in uterine leiomyomas.16,17 It is not known, however, how 
these mutations initiate the cascade of  events that eventually 
leads to the formation of  a fibroid. Some theorists suggest 
that intrinsic myometrial anomalies and endometrial injury 
play important roles. This is a plausible explanation of  
fibroid formation among menstruating adolescents, but it 
falls short of  explaining why some lesions appear sooner 
rather than later in adult life.18,19 It is possible that these 
lesions are congenitally acquired and exist at early childhood 
only to develop as a result of  sex steroid stimulation after 
menarche.20 Interestingly, a higher incidence of  leiomyomas 
have been observed among African women, in whom 
uterine leiomyomas also tend to occur at a younger age, 
with increased size, and are more frequently associated with 
symptoms.21,22 There is evidence that the expression of  
abnormal genes accounts for increased severity of  symptoms 
related to uterine leiomyomas among African women when 
compared to white women.22
The clinical presentation of  symptomatic uterine leiomyomas 
in adolescents may include irregular uterine bleeding, pelvic 
pain, and pressure symptoms, such as urinary frequency or 
urgency.19 Our patient presented with a pelvic mass without 
any abnormal uterine bleeding, which explains the normal 
haemoglobin level on admission. Physicians should be aware 
of  pelvic tumours, such as müllerian adenocarcinomas 
and sarcoma botryoides, which present as pelvic masses in 
adolescents.
The initial step in evaluating a woman with a pelvic mass 
is pelvic examination. If  leiomyoma is suspected, the initial 
diagnostic adjunct should be ultrasonography, owing to its 
diagnostic accuracy, cost-effectiveness, and wide availability.4 
Magnetic resonance imaging (MRI) represents the gold 
standard for the evaluation of  pelvic soft tissue tumours; 
however, the technology is not widely available in low-
resource settings.4 Computed tomography (CT) scanning is 
not recommended for the evaluation of  uterine leiomyomas.23
The treatment algorithm for uterine leiomyomas depends on 
the patient’s age and family planning goals, as well as tumour 
size and symptomatology. Asymptomatic leiomyomas can be 
kept under observation, with regular evaluation to eliminate 
the possibility of  malignant transformation.24
There are no treatment guidelines for symptomatic fibroids 
in adolescents. Surgical treatments such as myomectomy, 
myolysis, and hysterectomy can be employed when 
appropriate. Myomectomy is a common procedure 
performed for young women with symptomatic leiomyomas; 
it preserves fertility, does not interfere with the hormonal 
milieu of  the developing adolescent, and is associated with 
a low recurrence rate.19 Myomectomy can be performed by 
laparotomy, laparoscopy, or hysteroscopy, depending on the 
number, size, and location of  the fibroids. Hysterectomy is 
often performed for women with symptomatic leiomyomas 
who do not desire to retain fertility.25
Medical treatments and minimally invasive procedures can 
be performed in some cases to allow a more rapid recovery.26 
However, the use of  such treatments in adolescents 
lacks supportive evidence and little is known about their 
applicability to this group.19
Uterine artery embolization (UAE) is an additional option. 
In this procedure, the ascending branches of  the uterine 
artery supplying the leiomyomas are accessed and embolized 
to achieve complete loss of  fibroid perfusion. This causes 
necrosis and shrinkage of  the tumour.27 However, the 
potential complications associated with UAE (ovarian and 
fallopian tube damage resulting from impaired blood flow), 
may limit its applicability in adolescents who desire to retain 
fertility.28
Medical management is only used for short-term therapy 
because of  the significant risks associated with long-term 
treatment. Gonadotropin-releasing hormone (GnRH) 
agonists, selective oestrogen receptor modulators (SERMs), 
antiprogestins (RU486), and aromatase inhibitors have all 
been utilized.29 There is limited evidence available regarding 
the efficacy of  these medical interventions for managing 
uterine leiomyomas in the adolescent population.
Management of  symptomatic fibroids in adolescents can 
be challenging, with fertility preservation almost always a 
major priority, in addition to the patient’s safety and physical 
well-being. Physicians should offer pre- and post-procedure 
counselling regarding future fertility, recurrence following 
treatment, family planning options, and the importance of  
early and frequent antenatal visits when pregnant, as well as 
early completion of  family size. A high degree of  suspicion is 
important when encountering an young woman with a pelvic 
mass. Pelvic examination and ultrasonography are crucial to 
establish the diagnosis. Myomectomy is the best procedure 
in the adolescent group, in view of  preserving fertility. 
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Conclusions
Uterine leiomyomas should be considered in adolescent 
women presenting with a pelvic mass and abdominal pain. 
The management of  leiomyomas in this age group should be 
conservative, with the goal of  preserving fertility. Accurate 
evaluation of  the aetiology of  these tumours is important 
for future counselling.
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